BenzingaOctober 21, 2026 at 4:53 AM NY6 Days Ago
Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $400
Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $380 to $400.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
